Mihael H. Polymeropoulos

2010

In 2010, Mihael H. Polymeropoulos earned a total compensation of $3M as President and Chief Executive Officer at Vanda Pharmaceuticals, a 28% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$391,000
Option Awards$818,775
Salary$461,147
Stock Awards$1,312,750
Other$7,350
Total$2,991,022

Polymeropoulos received $1.3M in stock awards, accounting for 44% of the total pay in 2010.

Polymeropoulos also received $391K in non-equity incentive plan, $818.8K in option awards, $461.1K in salary and $7.4K in other compensation.

Rankings

In 2010, Mihael H. Polymeropoulos' compensation ranked 2,004th out of 10,439 executives tracked by ExecPay. In other words, Polymeropoulos earned more than 80.8% of executives.

ClassificationRankingPercentile
All
2,004
out of 10,439
81st
Division
Manufacturing
698
out of 3,838
82nd
Major group
Chemicals And Allied Products
136
out of 921
85th
Industry group
Drugs
77
out of 680
89th
Industry
Pharmaceutical Preparations
60
out of 481
88th
Source: SEC filing on April 28, 2011.

Polymeropoulos' colleagues

We found four more compensation records of executives who worked with Mihael H. Polymeropoulos at Vanda Pharmaceuticals in 2010.

2010

John Feeney

Vanda Pharmaceuticals

Chief Medical Officer

2010

James Kelly

Vanda Pharmaceuticals

Chief Financial Officer

2010

Stephanie Irish

Vanda Pharmaceuticals

Chief Financial Officer

2010

William Clark

Vanda Pharmaceuticals

Secretary

News

You may also like